JACOBS LEVY EQUITY MANAGEMENT, INC - CHECKMATE PHARMACEUTICALS IN ownership

CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 32 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$145,00036,5110.00%
Other shareholders
CHECKMATE PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 0$00.00%
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders